Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDowlais Regulatory News (DWL)

Share Price Information for Dowlais (DWL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 73.75
Bid: 73.70
Ask: 73.80
Change: -0.30 (-0.41%)
Spread: 0.10 (0.136%)
Open: 74.15
High: 74.55
Low: 73.60
Prev. Close: 74.05
DWL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reduction of Capital

10 Aug 2023 13:58

RNS Number : 9804I
Dowlais Group PLC
10 August 2023
 

10 August 2023

 

DOWLAIS GROUP PLC

 

Reduction of Capital

 

Dowlais Group plc (the "Company") is pleased to announce that, following formal approval by the High Court of Justice (the "Court") of the cancellation of the entire amount standing to the credit of the Company's share premium account (the "Capital Reduction") on 1 August 2023, the order of the Court confirming the Capital Reduction and statement of capital approved by the Court were registered with the Registrar of Companies on 10 August 2023 and the Capital Reduction has become effective. 

 

Details of the Capital Reduction, the purpose of which was to create distributable reserves, were set out in the prospectus published by the Company on 3 March 2023 for the admission of the issued share capital of the Company to the premium listing segment of the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange plc's main market for listed securities, and the Capital Reduction was approved by shareholders at a general meeting of the Company on 28 February 2023.

 

Following the Capital Reduction, the issued share capital of the Company has not changed and consists of 1,393,273,527 ordinary shares of £0.01 each.

 

 

 

Enquiries:

 

John Nicholson

General Counsel and Company Secretary

+44 (0)204 551 33833

LEI Number: 213800XM8WOFLY6VPC92

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMRZGVGFZM
Date   Source Headline
15th Apr 202411:25 amRNSDirector/PDMR Shareholding
15th Apr 20249:11 amRNSHolding(s) in Company
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20248:54 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20243:34 pmRNS2023 Annual Report and Notice of AGM
11th Apr 20249:52 amRNSHolding(s) in Company
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:46 amRNSHolding(s) in Company
9th Apr 20247:30 amRNSAppointment of Joint Corporate Broker
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20249:29 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSCommencement of £50m Share Buy-back Programme
25th Mar 20249:08 amRNSHolding(s) in Company
22nd Mar 20249:16 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFull Year Results 2023
20th Mar 20248:48 amRNSHolding(s) in Company
14th Mar 20243:03 pmRNSNotice of Results
16th Feb 20249:37 amRNSHolding(s) in Company
15th Feb 20244:16 pmRNSHolding(s) in Company
9th Feb 20249:15 amRNSHolding(s) in Company
1st Dec 20239:38 amRNSDirectorate Change
9th Nov 20237:00 amRNSTrading Statement
26th Oct 202312:49 pmRNSDirector/PDMR Shareholding
24th Oct 20234:04 pmRNSHolding(s) in Company
13th Oct 202312:32 pmRNSDirector/PDMR Shareholding
9th Oct 202310:46 amRNSHolding(s) in Company
2nd Oct 202312:44 pmRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSHalf-year Report
24th Aug 20234:00 pmRNSHolding(s) in Company
21st Aug 202311:25 amRNSHolding(s) in Company
10th Aug 20231:58 pmRNSReduction of Capital
29th Jun 202311:39 amRNSDirector/PDMR Shareholding
22nd Jun 202312:27 pmRNSDirector/PDMR Shareholding
21st Jun 202310:22 amRNSDirector/PDMR Shareholding
14th Jun 20239:01 amRNSHolding(s) in Company
5th Jun 202311:12 amRNSHolding(s) in Company
30th May 202310:01 amRNSDirector Declaration
23rd May 20239:46 amRNSHolding(s) in Company
23rd May 20237:00 amRNSTrading Statement
5th May 20232:59 pmRNSDirector/PDMR Shareholding
2nd May 202312:29 pmRNSDirector/PDMR Shareholding
28th Apr 202312:05 pmRNSHolding(s) in Company
27th Apr 202312:41 pmRNSDirector/PDMR Shareholding
27th Apr 202312:25 pmRNSDirector/PDMR Shareholding
27th Apr 202311:05 amRNSHolding(s) in Company
26th Apr 20234:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.